# AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

> **NCT04429919** · PHASE2 · COMPLETED · sponsor: **Algiax Pharmaceuticals GmbH** · enrollment: 99 (actual)

## Conditions studied

- Peripheral Post-surgical Neuropathic Pain

## Interventions

- **DRUG:** AP-325
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04429919
- **Lead sponsor:** Algiax Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-22
- **Primary completion:** 2024-10-04
- **Final completion:** 2024-10-04
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429919, "AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04429919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*